
Nirav Mehta
About Nirav Mehta
Data last updated:
Nirav Mehta is a Director at Maiva Pharma Private Limited (since 2024), Nominee Director at Ummeed Housing Finance Private Limited (since 2020) and Nominee Director at R.G. Scientific Enterprises Private Limited (since 2024), and holds 4 more current directorships. The companies operate in Pharma, Financial Services and Healthcare. The 6 current companies with reported revenue have a combined latest revenue of ₹1,489 Cr; the largest is Maiva Pharma Private Limited at ₹399 Cr (FY 2025). Earlier, Nirav Mehta was a Director at Morgan Stanley Investment Management Private Limited (2021–2025) and Director at Jana Capital Limited (2016–2025) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Apr 2024 | 1993 | ₹399 Cr (FY 2025) | Active | |
| Nominee Director | 26 Feb 2020 | 2016 | ₹317 Cr (FY 2025) | Active | |
| Nominee Director | 29 Oct 2024 | 1986 | ₹264 Cr (FY 2025) | Active | |
| Director | 07 Dec 2021 | 2010 | ₹259 Cr (FY 2025) | Active | |
| Director | 28 Jun 2023 | 2010 | ₹243 Cr (FY 2025) | Active | |
| Director | 30 Apr 2024 | 2022 | ₹5.70 Cr (FY 2025) | Active | |
| Nominee Director | 29 Oct 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 May 2021 | 1993 | ₹28.15 Cr (FY 2025) | Active | |
| Director | 10 Sep 2016 | 2015 | ₹7.3 Lakh (FY 2019) | Active | |
| Director | 06 Jul 2018 | 2013 | ₹2,845 Cr (FY 2025) | Active | |
| Alternate Director | 21 Dec 2016 | 1991 | ₹418 Cr (FY 2023) | Amalgamated | |
| Alternate Director | 14 Jun 2016 | 2006 | ₹6,375 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nirav Mehta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirav Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirav Mehta
Nirav Mehta currently holds 7 directorships: Maiva Pharma Private Limited (Director, since 30 Apr 2024, revenue ₹399 Cr (FY 2025)); Ummeed Housing Finance Private Limited (Nominee Director, since 26 Feb 2020, revenue ₹317 Cr (FY 2025)); R.G. Scientific Enterprises Private Limited (Nominee Director, since 29 Oct 2024, revenue ₹264 Cr (FY 2025)); Fullife Healthcare Private Limited (Director, since 07 Dec 2021, revenue ₹259 Cr (FY 2025)); Clearmedi Healthcare Private Limited (Director, since 28 Jun 2023, revenue ₹243 Cr (FY 2025)); and 2 more.
Nirav Mehta was first appointed on 14 Jun 2016 as Alternate Director at Jana Small Finance Bank Limited. The most recent appointment on record is 29 Oct 2024 at Rg Stone & Super Speciality Hospital Private Limited.
The 6 current companies of Nirav Mehta that report revenue have a combined latest revenue of ₹1,489 Cr: Maiva Pharma Private Limited ₹399 Cr (FY 2025); Ummeed Housing Finance Private Limited ₹317 Cr (FY 2025); R.G. Scientific Enterprises Private Limited ₹264 Cr (FY 2025); Fullife Healthcare Private Limited ₹259 Cr (FY 2025); Clearmedi Healthcare Private Limited ₹243 Cr (FY 2025); and 1 more.
Nirav Mehta held 5 earlier board appointments: Morgan Stanley Investment Management Private Limited (Director, 06 May 2021 to 31 Oct 2025); Jana Capital Limited (Director, 10 Sep 2016 to 09 Jan 2025); Nspira Management Services Private Limited (Director, 06 Jul 2018 to 16 Jan 2023); Zcl Chemicals Limited (Alternate Director, 21 Dec 2016 to 09 Mar 2021); Jana Small Finance Bank Limited (Alternate Director, 14 Jun 2016 to 30 Jan 2018).
The current boards of Nirav Mehta's companies include Arumugam Bhaskar Krishna (Maiva Pharma Private Limited), Buggana Hariharnath (Maiva Pharma Private Limited), Janardhan (Maiva Pharma Private Limited), Shivananda Kuppayya Hegde (Maiva Pharma Private Limited), Vaibhav Bagri (Maiva Pharma Private Limited), Alok Prasad (Ummeed Housing Finance Private Limited), among others.